Edition:
United States

Neptune Technologies & Bioressources Inc (NEPT.TO)

NEPT.TO on Toronto Stock Exchange

4.09CAD
17 Jul 2018
Change (% chg)

-- (--)
Prev Close
$4.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
281,305
52-wk High
$5.94
52-wk Low
$0.86

Latest Key Developments (Source: Significant Developments)

Neptune Technologies Says Entered Into A Multi-Year Agreement With Canopy Growth
Tuesday, 19 Jun 2018 07:30am EDT 

June 19 (Reuters) - Neptune Technologies & Bioressources Inc ::NEPTUNE TECHNOLOGIES & BIORESSOURCES INC - ENTERED INTO A MULTI-YEAR AGREEMENT WITH CANOPY GROWTH.NEPTUNE TECHNOLOGIES & BIORESSOURCES INC - NEPTUNE WILL SUPPLEMENT CANOPY GROWTH'S EXTRACTION, REFINEMENT, AND EXTRACT PRODUCT FORMULATION CAPACITY..  Full Article

Neptune Technologies & Bioressources Reports Q4 Revenue Of $7.0 Mln
Tuesday, 5 Jun 2018 04:48pm EDT 

June 5 (Reuters) - Neptune Technologies & Bioressources Inc ::NEPTUNE ANNOUNCES FOURTH QUARTER AND YEAR-END RESULTS.NEPTUNE TECHNOLOGIES & BIORESSOURCES - REVENUES WERE $7.0 MILLION FOR 3-MONTH PERIOD ENDED MARCH 31 VERSUS $11.8 MILLION FOR FOUR-MONTH PERIOD ENDED MARCH 31, 2017.NEPTUNE TECHNOLOGIES & BIORESSOURCES INC - NET LOSS WAS $4.8 MILLION FOR Q4, VERSUS $2.3 MILLION FOR FOUR-MONTH PERIOD ENDED MARCH 31, 2017.  Full Article

Relevium Announces Agreement With Neptune Wellness For Maxsimil
Monday, 30 Apr 2018 11:20am EDT 

April 30 (Reuters) - Relevium Technologies Inc ::RELEVIUM ANNOUNCES AGREEMENT WITH NEPTUNE WELLNESS FOR MAXSIMIL®.RELEVIUM TECHNOLOGIES INC - PRODUCT DEVELOPMENT, SUPPLY & COMMERCIALIZATION DEAL WITH NEPTUNE WELLNESS SOLUTIONS FOR MAXSIMIL.RELEVIUM - INITIAL 2-YEAR TERM ON AGREEMENT WITH NEPTUNE WELLNESS FOR MAXSIMIL, DEVELOPMENT OF 2 PRODUCTS IN YEAR 1, AN ADDITIONAL 6 WITHIN YEAR 2.  Full Article

Neptune Technologies Announces Research Agreement Aimed At Medical Cannabinoid-Based Products
Friday, 19 Jan 2018 08:00am EST 

Jan 19 (Reuters) - Neptune Technologies & Bioressources Inc ::NEPTUNE ANNOUNCES RESEARCH AGREEMENT AIMED AT NEW MEDICAL AND WELLNESS CANNABINOID-BASED PRODUCTS.NEPTUNE TECHNOLOGIES & BIORESSOURCES-ANNOUNCED EXCLUSIVE RESEARCH AGREEMENT FOR DEVELOPING NEW MEDICAL, WELLNESS TARGETED CANNABINOID-BASED PRODUCTS​.NEPTUNE TECHNOLOGIES & BIORESSOURCES INC - ‍ REACHED THE EXCLUSIVE RESEARCH AGREEMENT WITH A KRILL OIL PROVIDER​.  Full Article

Neptune Technologies Extends Global Maxsimil Licence To Cannabis-Derived Products​
Monday, 27 Nov 2017 08:00am EST 

Nov 27 (Reuters) - Neptune Technologies & Bioressources Inc ::NEPTUNE TECHNOLOGIES & BIORESSOURCES - CO EXTENDS GLOBAL MAXSIMIL LICENCE TO CANNABIS-DERIVED PRODUCTS​.  Full Article

Neptune Q2 revenue C$6.8 million versus C$11.6 million
Tuesday, 14 Nov 2017 04:05pm EST 

Nov 14 (Reuters) - Neptune Technologies & Bioressources Inc :Neptune announces second quarter results.Q2 revenue C$6.8 million versus C$11.6 million.Neptune Technologies & Bioressources Inc - ‍gain of $23.9 million realized from sale of Krill Oil business​.Neptune Technologies & Bioressources Inc - ‍net income was $20.0 million for quarter, versus a net loss of $0.7 million in prior year​.  Full Article

Neptune and Ingenutra signs exclusive worldwide agreement for MaxSimil
Friday, 7 Oct 2016 08:07am EDT 

Neptune Technologies & Bioressources Inc : Terms also cover potential collaboration between both companies on clinical trials . Neptune Technologies & Bioressources Inc says all other terms of agreement remain confidential . Neptune and Ingenutra sign an exclusive worldwide agreement for Maxsimil . All other terms of agreement remain confidential. . Agreement allows neptune to manufacture, distribute and sell Maxsimil in nutraceutical field worldwide .Says agreement is valid till 2028.  Full Article